Confirming Cancer Early
The IvyGene™ test is a simple blood test that confirms the presence of cancer, as early as stage 1, and give measurable information about cancer. The IvyGene test combines advanced sequencing techniques to confirm the presence of multiple cancer types and provides a highly accurate tool for physicians to gain insight into their patients’ health, at the time of testing.
The IvyGene™ test has been validated with four (4) cancer types: breast, colon, liver and lung cancers. The presence of other cancer types may also result in an elevated IvyGene™ Score.
Conferences, News, & Events
Alcami Donates to Wilmington Firefighters’ Cancer Detection
Durham-based Alcami has donated $15,000 to the Wilmington, North Carolina Fire Department to help fund IvyGene cancer screenings for firefighters, who face above-average risk of developing cancer.
The building blocks of IvyGene were published in Nature Materials
Learn more about DNA Methylation and how this technology is being used in revolutionary new ways. Visit the link to learn more: www.nature.com/nmat
Dhruvajyoti Roy, PhD, director of technology for LAM, owners of the IvyGene technology, agrees that the combination vaccine has potential for clinical development.
Stop by and visit our booth at our upcoming conferences.
Society of Integrative Oncology (SIO)
October 27-29, 2018 – Scottsdale, AZ
Age Management Medicine Group (AMMG)
November 11-4, 2018 – Tucson, AZ